Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1489–1512 of 13,363 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Intracranial CNS Disorder Clear all

Conditions: Alzheimer Disease, Late Onset
Interventions: CSF analysis, Functional MRI; Diagnostic Test · Radiation
Lead sponsor: Ohio State University; Other
Eligibility: 60 Years to 95 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Migraine
Interventions: Treximet, Placebo; Drug
Lead sponsor: Premiere Research Institute; Other
Eligibility: 12 Years to 17 Years
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 4
States / cities: West Palm Beach, Florida • Cincinnati, Ohio • Dallas, Texas + 1 more

Conditions: Generalized Epilepsy, Infantile Spasms, Metabolic Disease, Partial Epilepsy, Seizures
Interventions: 18 FDG; Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1992 – 2004
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, High Grade Glioma, GBM, Brain Cancer
Interventions: Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB); Procedure
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Parkinson's Disease
Interventions: Reparative Autologous peripheral nerve tissue; Procedure
Lead sponsor: Craig van Horne, MD, PhD; Other
Eligibility: 45 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Alzheimer Disease, Physical Activity
Interventions: Beat-accentuated, personalized music stimulation (BMS), Strength Training (ST), Aerobic exercise (AE); Behavioral
Lead sponsor: Emory University; Other
Eligibility: 65 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Atlanta, Georgia • Greensboro, North Carolina

Conditions: Atrial Fibrillation, Dementia, Cognitive Decline
Interventions: Questionnaire, Magnetic Resonance Imaging; Other · Diagnostic Test
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 65 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Murray, Utah

Conditions: Dementia, Elder Abuse, Elder Mistreatment
Interventions: SIRENS application, SIRENS screening; Behavioral · Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 21 Years and older
Enrollment: 774 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, ALS-Frontotemporal Dementia, Primary Lateral Sclerosis, Progressive Muscular Atrophy
Interventions: Not listed
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 610 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2031
U.S. locations: 3
States / cities: Miami, Florida • Kansas City, Kansas • Philadelphia, Pennsylvania

Conditions: Parkinson Disease
Interventions: delayed feedback; Behavioral
Lead sponsor: Kessler Foundation; Other
Eligibility: 55 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Childhood-onset Growth Hormone Deficiency, Pituitary Dwarfism
Interventions: recombinant human growth hormone; Biological
Lead sponsor: EMD Serono; Industry
Eligibility: 13 Years to 25 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 9
States / cities: Orange, California • Jacksonville, Florida • Orlando, Florida + 6 more

Conditions: ADHD - Attention Deficit Disorder With Hyperactivity
Interventions: methylphenidate hydrochloride (Jornay PM); Drug
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 6 Years to 17 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Parkinson Disease
Interventions: Low Vision Occupational Therapy; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Analgesic Rebound Headache
Interventions: Almotriptan, Topiramate; Drug
Lead sponsor: The New England Center for Headache, P.C.; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 1
States / cities: Stamford, Connecticut

Conditions: Pompe Disease
Interventions: ATB200, AT2221; Drug
Lead sponsor: Amicus Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 12
States / cities: Phoenix, Arizona • Orange, California • Gainesville, Florida + 9 more

Conditions: Rehabilitation, Recovery of Function, Stroke
Interventions: Duck Duck Punch Play, Commercially Available Game Play; Device · Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years to 90 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Heart Diseases
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 21 Years to 95 Years
Enrollment: 5,302 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2004
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Parkinson Disease, Parkinsonism, Lewy Body Disease, Supranuclear Palsy, Progressive, Parkinsonism Vascular, Multiple System Atrophy, Corticobasal Degeneration, Alzheimer Disease, Frontotemporal Dementia, Primary Progressive Aphasia, Vascular Dementia
Interventions: Palliative Care; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 105 Years
Enrollment: 783 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: San Francisco, California • Aurora, Colorado

Conditions: Alzheimer Disease, Dementia, Caregiver Stress
Interventions: Tele Savvy for Latino Caregivers; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Central Nervous System Tumor, Brain Tumor, Spinal Tumor
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 2 Years to 18 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Altered Mental Status, Generalized Nonconvulsive Seizure Disorder, Status-epilepticus
Interventions: Not listed
Lead sponsor: Bio-Signal Group Corp.; Industry
Eligibility: 13 Years and older
Enrollment: 261 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Dementia
Interventions: Amantadine, Placebo; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 40 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Parkinson Disease, Sleep Disturbance
Interventions: Tailored Lighting Intervention (TLI), Actigraph; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Traumatic Brain Injury, Cognitive Decline, Vascular Dementia
Interventions: No intervention. This is an observational study.; Other
Lead sponsor: Walter Reed National Military Medical Center; Federal
Eligibility: 18 Years to 74 Years
Enrollment: 300 participants
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Synaptic Injury and Functional Connectivity in Alzheimer's Disease

Treximet Early Intervention Adolescent Migraine

Metabolic Abnormalities in Children With Epilepsy

Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma

A Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Brain for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery

Inspiring Seniors Towards Exercise Promotion to Protect Cognition

PLUG Dementia Trial and MRI PLUG Dementia Sub-Study

Primary Care Screening and Intervention for Patients With Dementia and Caregivers

TRIAL READY (Clinical Trial Readiness)

Investigation of Effects of Delayed Feedback on Non-motor Symptoms in Individuals With Parkinson's Disease

Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency

Medication Treatment of ADHD in Pediatric Epilepsy

Low Vision Occupational Therapy in Parkinson's Disease

Detoxification and Treatment of Subjects With Medication Overuse Headache

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

Functional Viability Duck Duck Punch

Identifying Genes That May Increase the Risk for Heart Disease in African Americans

More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease

Tele-Savvy for Latino Caregivers

Medical Marijuana in the Pediatric Central Nervous System Tumor Population

Putting Electroencephalography (EEG) in the Emergency Department

Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)

The Effect of a Lighting Intervention on Sleep in Parkinson Disease

Cognitive and Vascular Functioning Following TBI